Literature DB >> 28339291

Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.

Marian Garcia-Nuñez1,2,3,4, Sara Marti1,5, Carmen Puig1,5, Vicente Perez-Brocal6,7,8, Laura Millares1,2,3,4, Salud Santos1,9, Carmen Ardanuy1,5, Andres Moya6,7,8, Josefina Liñares1,5, Eduard Monsó1,2,3,4.   

Abstract

AIM: The bronchial microbiome of severe chronic obstructive pulmonary disease patients colonized by Pseudomonas aeruginosa was analyzed using 16S rRNA gene sequencing to identify differences related to biofilm-forming capacity. PATIENTS &
METHODS: Patient sputum samples from 21 patients were studied.
RESULTS: Statistically significant differences related to biofilm-forming capacity were only found for genera with relative abundances <1%, and Fusobacterium was over-represented when biofilm-forming capacity was high. Genera with relative abundances >50% which increased from baseline were observed in 10/14 exacerbations, but corresponded to Pseudomonas only in three episodes, while other pathogenic genera were identified in seven.
CONCLUSION: The bronchial microbiome shows differences according with P. aeruginosa biofilm-forming capacity. Pathogenic microorganisms other than P. aeruginosa cause a significant part of the exacerbations in colonized chronic obstructive pulmonary disease patients.

Entities:  

Keywords:  16S rRNA; P. aeruginosa; biofilm; exacerbation; lung microbiome; severe COPD

Mesh:

Substances:

Year:  2017        PMID: 28339291     DOI: 10.2217/fmb-2016-0127

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  11 in total

Review 1.  Microbiome in chronic obstructive pulmonary disease.

Authors:  Eduard Monsó
Journal:  Ann Transl Med       Date:  2017-06

2.  Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation.

Authors:  Sebastián A Riquelme; Kalle Liimatta; Tania Wong Fok Lung; Blanche Fields; Danielle Ahn; David Chen; Carmen Lozano; Yolanda Sáenz; Anne-Catrin Uhlemann; Barbara C Kahl; Clemente J Britto; Emily DiMango; Alice Prince
Journal:  Cell Metab       Date:  2020-05-18       Impact factor: 27.287

3.  Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients.

Authors:  Marco Artini; Rosanna Papa; Filippo Sapienza; Mijat Božović; Gianluca Vrenna; Vanessa Tuccio Guarna Assanti; Manuela Sabatino; Stefania Garzoli; Ersilia Vita Fiscarelli; Rino Ragno; Laura Selan
Journal:  Microorganisms       Date:  2022-04-24

4.  Diagnostic Value of Endotracheal Aspirates Sonication on Ventilator-Associated Pneumonia Microbiologic Diagnosis.

Authors:  Laia Fernández-Barat; Ana Motos; Otavio T Ranzani; Gianluigi Li Bassi; Elisabet Aguilera Xiol; Tarek Senussi; Chiara Travierso; Chiara Chiurazzi; Francesco Idone; Laura Muñoz; Jordi Vila; Miquel Ferrer; Paolo Pelosi; Francesco Blasi; Massimo Antonelli; Antoni Torres
Journal:  Microorganisms       Date:  2017-09-20

5.  Potential of Health and Demographic Surveillance System in Asthma and Chronic Obstructive Pulmonary Disease Microbiome Research.

Authors:  Dhiraj Agarwal; Dhiraj Dhotre; Rutuja Patil; Yogesh Shouche; Sanjay Juvekar; Sundeep Salvi
Journal:  Front Public Health       Date:  2017-08-04

Review 6.  Natural Killer Cells in the Lungs.

Authors:  Jingjing Cong; Haiming Wei
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 7.  Airway immunometabolites fuel Pseudomonas aeruginosa infection.

Authors:  Sebastián A Riquelme; Alice Prince
Journal:  Respir Res       Date:  2020-12-10

8.  In Vivo Activity of Metal Complexes Containing 1,10-Phenanthroline and 3,6,9-Trioxaundecanedioate Ligands against Pseudomonas aeruginosa Infection in Galleria mellonella Larvae.

Authors:  Megan O'Shaughnessy; Magdalena Piatek; Pauraic McCarron; Malachy McCann; Michael Devereux; Kevin Kavanagh; Orla Howe
Journal:  Biomedicines       Date:  2022-01-21

9.  The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.

Authors:  Yu Jia; Tiantian He; Di Wu; Jiabing Tong; Jie Zhu; Zegeng Li; Jingcheng Dong
Journal:  J Transl Med       Date:  2022-06-21       Impact factor: 8.440

Review 10.  Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.

Authors:  Irene Jurado-Martín; Maite Sainz-Mejías; Siobhán McClean
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.